Any current/future new fundraising through debt or equity?

There is no specific mention of any current or future new fundraising through debt or equity in the provided pages (Page 1 to 21) of the transcript. The discussion primarily focuses on business performance, growth strategies, claims management, regulatory environment, and technology platform transitions. No explicit statements or plans about raising capital via debt or equity were disclosed during the call or in closing remarks.

Future growth expectations in sales/revenue/volumes?

Star Health aims for profitable, sustainable growth rather than just market share expansion. Fresh retail growth is expected to remain strong with a focus on value and volume; fresh retail growth was 38% YoY in Q4 FY26. New-to-insurance mix remains high (~94%-95% on fresh premium), targeting new, profitable customer cohorts. Company projects NEP growth of upwards of 39% for FY26 and expects this to improve further with long-term policies accruing in NEP. Growth targets include maintaining a steady state industry growth alignment of 70-80% overall. Focus on profitable geographies and segments l

Future growth expectations in earnings/operating earnings/profits/EPS?

Star Health expects steady growth on an N basis with upwards of 39% growth for FY26. Profitable growth remains a key focus, targeting profitable geographies and consumer cohorts rather than just market share expansion. Fresh retail business growth driven by both value and volume, with retail policies expanding by 11% YoY in Q4 FY26. Continued price increases planned, aligned with product performance and actuarial principles. Loss ratio improvements expected to sustain due to repricing and better portfolio mix, supporting underwriting profitability. Normalized profit after tax rose 45% YoY in F

IN US

Sale is live|00:00:00left today

Star Health & Allied Insurance Company LtdQ1 FY26Insurance

Star Health & Allied Insurance Company Ltd Q1 FY26 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹577P/E: 55.5Market Cap: ₹30.9K CrSector: Insurance

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

N/A

0 of 2 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 2

→Star Health aims for profitable, sustainable growth rather than just market share expansion.
→Fresh retail growth is expected to remain strong with a focus on value and volume; fresh retail growth was 38% YoY in Q4 FY26.
→New-to-insurance mix remains high (~94%-95% on fresh premium), targeting new, profitable customer cohorts.
→Company projects NEP growth of upwards of 39% for FY26 and expects this to improve further with long-term policies accruing in NEP.
→Growth targets include maintaining a steady state industry growth alignment of 70-80% overall.
→Focus on profitable geographies and segments like SME with growth targets aligned to organizational objectives.
→Agent base expansion planned: adding 100,000 agents annually, targeting 1 million agents in the next two years.
→Aim to sustain mid-to-high-teen growth rates with a strong retail franchise supported by digital and operational efficiencies.

Margin guidance

Category 3

→Star Health expects steady growth on an N basis with upwards of 39% growth for FY26.
→Profitable growth remains a key focus, targeting profitable geographies and consumer cohorts rather than just market share expansion.
→Fresh retail business growth driven by both value and volume, with retail policies expanding by 11% YoY in Q4 FY26.
→Continued price increases planned, aligned with product performance and actuarial principles.
→Loss ratio improvements expected to sustain due to repricing and better portfolio mix, supporting underwriting profitability.
→Normalized profit after tax rose 45% YoY in FY26 to Rs. 1,222 crore with ROE expanding from 10.1% to 13.1%.
→Digital and proprietary distribution channels to drive growth and deepen market penetration.
→Transition to IND AS accounting from FY27 expected to normalize reported earnings.
→Full platform migration to Medi Assist claims processing by quarter-end to improve efficiency and customer experience.

3 more insights locked — sign up free to unlock

Fundraise plans

→There is no specific mention of any current or future new fundraising through debt or equity in the provided pages (Page 1 to 21) of the transcript.
→The discussion primarily focuses on business performance, growth strategies, claims management, regulatory environment, and technology platform transitions.
→No explicit statements or plans about raising capital via debt or equity were disclosed during the call or in closing remarks.

Order book

The provided pages from the document do not contain specific information regarding the current or expected order book or pending orders. The discussion primarily revolves around: - Loss ratios and underwriting improvements. - Pricing strategies and impact of external environment. - Claims processing and technology platform transition. - Growth strategies in retail and group health segments. - Regulatory environment and initiatives like Public Insurance Registry (PIR). - Agent network expansion and digital engagement metrics. No explicit data or commentary on order book status or pending orders was mentioned on the referenced pages. If you need detailed insights on order book or pending orders, please provide pages containing such information or specify if there's another section to check.

Capex plans

The transcript does not explicitly mention specific current or future capex or strategic capital investments. However, relevant points indicating investment focus include: - Continued investment in technology platforms, especially the Medi Assist platform for claims processing, improving efficiency and customer experience. - Ongoing digital investments to enhance productivity, service outcomes, platform modernization, workflow automation, and AI deployment. - Significant investment in agent upskilling and technology-enabled Learning & Development to improve productivity and maintain agent stickiness. - Support and stakeholding in the Bima Sugam platform to promote affordable insurance and a service-oriented ecosystem. - Institutionalization and scaling of wellness-based consumer ecosystem capabilities, including Telemedicine and Home Health Care services. No specific capex quantum or timelines were disclosed, but the company's focus on technology and digital transformation indicates ongoing strategic investments.

How does Star Health & Allied Insurance Company Ltd rank vs peers in Insurance?

Pro feature

1Star Health & Allied Insurance Company Ltd

Rev 2Mar 3

See full Insurance sector rankings

Want more stocks like Star Health & Allied Insurance Company Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio